Important: The POPLINE website will retire on September 1, 2019. Click here to read about the transition.

Your search found 1 Results

  1. 1
    Peer Reviewed

    Universal access to antiretroviral therapy: when, not if.

    Carpenter CC

    Clinical Infectious Diseases. 2006 Jan 15; 42(2):260-261.

    The global HIV/AIDS pandemic poses the greatest global health challenge in recent history. Effective, large-scale treatment of the several million infected individuals has appeared to present an almost insurmountable task. An ambitious global approach to this challenge was developed by the World Health Organization (WHO) "3 by 5" program in 2003, with the goal of providing treatment to 3 million affected individuals in low- and middle-income countries by the end of 2005. Although the immediate goal of the "3 by 5" program has not been achieved, 1500,000 Africans are now receiving antiretroviral therapy (ART). This initial WHO initiative has been of tremendous value in shifting the international emphasis from "if" to "when" universal access to antiretroviral treatment can be achieved. An additional thoughtful analysis of the essential elements of an effective approach to worldwide scale-up of ART was presented by the Institute of Medicine in early 2005. (excerpt)
    Add to my documents.